Health Care
Commentary
Drug Price Controls Threaten Cancer Cures
A federal judge in New Jersey recently dismissed a lawsuit seeking to strike down the Inflation Reduction Act’s program of price controls for prescription drugs dispensed through Medicare. It was the fifth suit of its kind to fail this year. Democrats have cheered the IRA’s price controls for supposedly making ...
Commentary
Learn more about saving Medicaid
Trump can fix Medicaid
Republicans in Congress are eyeing cuts to Medicaid, the entitlement that provides health coverage to roughly 1 in 5 people. Requiring beneficiaries to work, volunteer, or attend school as a condition of receiving coverage and block-granting federal Medicaid funds to the states are under consideration. But with complete control of ...
Commentary
Learn more about Medicare reform
Medicare Reform Can Wait No Longer
Few components of America’s healthcare system are more in need of reform than Medicaid, the joint federal-state public health plan for low-income Americans. And with Republicans set to control the House, Senate, and executive branch next year, there’s finally a chance to address the program’s considerable problems. The most serious ...
Biosimilars
The Biosimilar Promise
Despite Achievements, Barriers That Discourage Biosimilar Use Remain
Despite Achievements, Barriers That Discourage Biosimilar Use Remain By Wayne Winegarden | December 2, 2024 READ PDF Executive Summary The Inflation Reduction Act’s price controls discourage biosimilar development. Payment system inefficiencies, such as the buy-and-bill payment system and rebate walls, disincentivize the use of lower cost biosimilars. Despite the savings ...
Commentary
Learn more about healthcare reform
It’s time to give power to medical patients
America’s health bill will surpass $7.7 trillion by 2032, according to the most recent federal data. That’s equivalent to one in every five dollars flowing through the economy. And it’s completely unsustainable. To address this crisis, we must make health care work like other sectors of our economy, rather than ...
Commentary
Learn more about healthcare reform
Here’s How The Trump Administration Can Help Small Businesses Pay For Health Care
What does Donald Trump’s second term portend for health care? Patients should hope it’s a lot like his first term. During his first four years in the White House, Trump took a number of steps to give small businesses more healthcare choices—and reduce what they’d have to pay for coverage. ...
Commentary
Learn more about healthcare reform
Now Trump Has Chance to Finish His Work on Healthcare
When he takes office early next year, President-elect Donald Trump will have a rare opportunity to remake America’s healthcare system for the better. To do so, he’ll need to follow through on some of the best policy ideas from his first term while taking additional steps to bring more choice, ...
Commentary
Learn more about healthcare reform
Five ways Trump can improve healthcare
President-elect Donald Trump famously stated he has “concepts of a plan” for healthcare reform. Now, those concepts may soon become reality. Here are five ways Trump and a Republican Congress can reduce health costs and expand access to affordable healthcare. Read the entire op-ed here.
affordability boards
Learn more about drug pricing
Drug ‘affordability’ boards won’t really help patients
Colorado’s Prescription Drug Affordability Board recently declared that Stelara, a popular treatment for Crohn’s disease and other autoimmune conditions, is “unaffordable.” Soon, the board’s five unelected members could decide whether to impose an “upper payment limit” on the medication. The decision could have significant consequences not just in Colorado but ...
Commentary
Learn more about how price controls hurt consumers
Yet More Evidence That Price Controls Are Bad For Patients
The Democrats’ days in control of federal healthcare policy are numbered. But they were able to do quite a bit of damage during President Biden’s term. The scheme of price controls they’ve put in place for drugs dispensed through Medicare is a case in point. Ten drugs in Medicare Part ...
Drug Price Controls Threaten Cancer Cures
A federal judge in New Jersey recently dismissed a lawsuit seeking to strike down the Inflation Reduction Act’s program of price controls for prescription drugs dispensed through Medicare. It was the fifth suit of its kind to fail this year. Democrats have cheered the IRA’s price controls for supposedly making ...
Learn more about saving Medicaid
Trump can fix Medicaid
Republicans in Congress are eyeing cuts to Medicaid, the entitlement that provides health coverage to roughly 1 in 5 people. Requiring beneficiaries to work, volunteer, or attend school as a condition of receiving coverage and block-granting federal Medicaid funds to the states are under consideration. But with complete control of ...
Learn more about Medicare reform
Medicare Reform Can Wait No Longer
Few components of America’s healthcare system are more in need of reform than Medicaid, the joint federal-state public health plan for low-income Americans. And with Republicans set to control the House, Senate, and executive branch next year, there’s finally a chance to address the program’s considerable problems. The most serious ...
The Biosimilar Promise
Despite Achievements, Barriers That Discourage Biosimilar Use Remain
Despite Achievements, Barriers That Discourage Biosimilar Use Remain By Wayne Winegarden | December 2, 2024 READ PDF Executive Summary The Inflation Reduction Act’s price controls discourage biosimilar development. Payment system inefficiencies, such as the buy-and-bill payment system and rebate walls, disincentivize the use of lower cost biosimilars. Despite the savings ...
Learn more about healthcare reform
It’s time to give power to medical patients
America’s health bill will surpass $7.7 trillion by 2032, according to the most recent federal data. That’s equivalent to one in every five dollars flowing through the economy. And it’s completely unsustainable. To address this crisis, we must make health care work like other sectors of our economy, rather than ...
Learn more about healthcare reform
Here’s How The Trump Administration Can Help Small Businesses Pay For Health Care
What does Donald Trump’s second term portend for health care? Patients should hope it’s a lot like his first term. During his first four years in the White House, Trump took a number of steps to give small businesses more healthcare choices—and reduce what they’d have to pay for coverage. ...
Learn more about healthcare reform
Now Trump Has Chance to Finish His Work on Healthcare
When he takes office early next year, President-elect Donald Trump will have a rare opportunity to remake America’s healthcare system for the better. To do so, he’ll need to follow through on some of the best policy ideas from his first term while taking additional steps to bring more choice, ...
Learn more about healthcare reform
Five ways Trump can improve healthcare
President-elect Donald Trump famously stated he has “concepts of a plan” for healthcare reform. Now, those concepts may soon become reality. Here are five ways Trump and a Republican Congress can reduce health costs and expand access to affordable healthcare. Read the entire op-ed here.
Learn more about drug pricing
Drug ‘affordability’ boards won’t really help patients
Colorado’s Prescription Drug Affordability Board recently declared that Stelara, a popular treatment for Crohn’s disease and other autoimmune conditions, is “unaffordable.” Soon, the board’s five unelected members could decide whether to impose an “upper payment limit” on the medication. The decision could have significant consequences not just in Colorado but ...
Learn more about how price controls hurt consumers
Yet More Evidence That Price Controls Are Bad For Patients
The Democrats’ days in control of federal healthcare policy are numbered. But they were able to do quite a bit of damage during President Biden’s term. The scheme of price controls they’ve put in place for drugs dispensed through Medicare is a case in point. Ten drugs in Medicare Part ...
